Table 1.

Participant characteristics by metabolic syndrome, the EAGeR Trial (2007–2011) (n=1174)^a

	Metabolic syndrome (score ≥3)^b n=229		No metabolic syndrome (score <3)^b n=945
Race (n, %)
White	220	96	893	94
Non-white	9	4	52	6
Education (n, %)
<high school	5	2	18	2
High school	29	13	108	11
>high school	195	85	818	87
Income (n, %)
<$40,000	89	39	303	32
$40,000-<$100,000	51	22	262	28
≥$100,000	89	39	379	40
Partner status (n, %)
Married	203	89	873	92
Living with partner	20	9	50	5
Other	6	3	22	2
Smoking (n, %)
Yes	18	8	38	4
No	211	92	907	96
Parous (n, %)
Yes	127	55	498	53
No	102	45	447	47
Number of prior losses (n, %)
1	144	63	645	68
2	85	37	300	32
Time since last loss (n, %)
<4 months	116	51	500	53
4-<8 months	36	16	169	18
8-<12 months	26	11	77	8
≥12 months	46	20	185	20
Treatment assignment (n, %)
Low-dose aspirin	106	46	489	52
Placebo	123	54	456	48
Age (years; mean [SD])	28.8	5.0	28.7	4.8
Body mass index (kg/m²; mean [SD])	33.2	6.6	24.5	5.0
Waist circumference (cm; mean, SD)	104.4	13.0	82.6	12.3
Triglycerides (mg/dL; mean, SD)	200.0	87.9	99.4	44.8
High-density lipoprotein (mg/dL; mean, SD)	39.5	7.3	53.6	11.8
Systolic blood pressure (mmHg; mean, SD)	122.0	12.4	109.0	10.6
Diastolic blood pressure (mmHg; mean, SD)	80.1	9.3	70.6	8.4
Glucose (mg/dL; mean, SD)	87.8	15.1	80.0	12.4

Table excludes 54 women who were missing one or more component of metabolic syndrome

Metabolic syndrome score = waist circumference ≥88 cm + triglycerides ≥150 mg/dL + high-density lipoprotein ≥50 mg/dL + (systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg) + glucose ≥100 mg/dL